HiberCell logo

HiberCell

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

25 employees · est. 2019 · New York, United States

VS
Riboscience logo

Riboscience

Riboscience is a biotechnology company developing treatments for serious infectious diseases and cancer

16 employees · est. 2012 · Sunnyvale, United States

Riboscience is the older company (2019 vs 2012).

Side-by-Side Comparison

HiberCell Riboscience
Founded
2019 2012 older
Headquarters
New York, United States Sunnyvale, United States
Employees
25 16
Industry
Biotechnology, Health Care Biotechnology, Information Technology
Funding Stage
Unknown Not tracked yet
Total Funding
$128.20M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Development of therapeutic candidates (HC-7366, HC-5404), Clinical-stage research and trials, Exploiting stress-driven vulnerabilities in cancer cells Not tracked yet
Target Customers
Cancer patients, Healthcare providers, Biotech investors, Oncologists Not tracked yet
Taxonomy
Oncology, Therapeutics, Cancer, Metastasis, Clinical Stage, Adaptive Stress Pathways, Anti-tumor Immunity, Product Candidates, Phase 1a Clinical Trials, Cancer Relapse Prevention, New York, Treatment Resistance, Stress Response Kinases, Innate Immune Response Infectious Diseases, Cancer Treatments, Clinical Stage, Drug Discovery, Ribose, Structure-guided Design, Protein Targeting, Pathogen, Tumor Cells, Anti-tumor Immune Response
Website
hibercell.com riboscience.com
HiberCell logo

About HiberCell

HiberCell, founded in 2019 and headquartered in the United States, is a pioneering force in the Biotechnology and Health Care industries. With a focus on developing novel therapeutics, the company aims to prevent cancer relapse and metastasis. Its slogan, "Developing Novel Therapeutics to Prevent Ca...

Riboscience logo

About Riboscience

Riboscience is a biotechnology company founded in 2012, headquartered in the United States. The company's slogan, "Riboscience is a biotechnology company developing treatments for serious infectious diseases and cancer," aptly captures its focus. Riboscience is at the clinical stage and focuses on d...

We will tell you when either one moves

BounceWatch watches HiberCell and Riboscience for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at HiberCell and Riboscience — by email.

Frequently Asked Questions

HiberCell — Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis. Riboscience — Riboscience is a biotechnology company developing treatments for serious infectious diseases and cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
HiberCell has raised $128.20M while Riboscience has raised undisclosed funding.
HiberCell and Riboscience operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare HiberCell with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at HiberCell on 12 Sep 2024, and Riboscience on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy